# National Evaluation of Patients With PIK3CA-Related Overgrowth Spectrum (PROS)

> **NCT05563831** · — · COMPLETED · sponsor: **Institut National de la Santé Et de la Recherche Médicale, France** · enrollment: 28 (actual)

## Conditions studied

- PIK3CA-related Overgrowth Spectrum
- CLOVES Syndrome
- Klippel Trenaunay Syndrome
- Megalencephaly
- MCAP
- Macrodactyly
- Vascular Malformations
- Lymphatic Malformation
- Venous Malformation

## Interventions

- **OTHER:** national registry

## Key facts

- **NCT ID:** NCT05563831
- **Lead sponsor:** Institut National de la Santé Et de la Recherche Médicale, France
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-02-21
- **Primary completion:** 2023-06-07
- **Final completion:** 2023-06-07
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2026-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05563831

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05563831, "National Evaluation of Patients With PIK3CA-Related Overgrowth Spectrum (PROS)". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT05563831. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*